Molecule to Market Podcast: M&A Roundtable and 2024 Predictions

Mar 2024

Originally posted by Molecule to Market on March 8, 2024.

James West, Managing Director in Lincoln’s Healthcare Group, recently joined the Molecule to Market podcast’s roundtable episode where he shared an update on the life sciences sector.

Listen to the podcast.

Summary

Contributor

Meet Professionals with Complementary Expertise in Healthcare

Related Perspectives in Healthcare

Investors in Healthcare | Q&A with Lincoln Professionals

Originally posted by Investors in Healthcare on July 25, 2024. Lincoln International, the U.S.-headquartered global investment banking advisor, is a well-known name in the European healthcare markets, providing advice to… Read More

Outlook in the EU: PE has Ophthalmology Sector in its Sights

Across Europe, private clinics and specialist outpatient healthcare providers such as ophthalmology practices have seen a wave of consolidation, which has led to the emergence of several pan-European and more… Read More

Real Deals | Maintaining Momentum: The Outlook for M&A in the Healthcare Sector

Originally posted by Real Deals on May 31, 2024. RD: Which sub-sector of healthcare is currently attracting the most investment? Dirk-Oliver Löffler: Provider business is still one of the core… Read More

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More